世界の腎細胞がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Renal Cell Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5989
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、118ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、腎細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・腎細胞がん治療の市場動向
・企業の競争状況、市場シェア
・腎細胞がん治療の種類別市場規模と予測2016-2027（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）
・腎細胞がん治療の用途別市場規模と予測2016-2027（病院、薬局、その他）
・腎細胞がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・腎細胞がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・腎細胞がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・腎細胞がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・腎細胞がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Bristol-Myers Squibb、Roche、GSK、Novartis、Bayer、Merck & Co.、Exelixis、Takeda、Eisai、CTTQ、AVEO Oncology、Everest Pharm、Cipla、NATCO、Beacon Pharma、SAMARTH）
・結論

Renal Cell Cancer Treatment — also called renal cancer — is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma.
Renal cell carcinoma (RCC) is a common malignant tumor worldwide, referred to as kidney cancer. According to the World Health Organization, the global incidence of kidney cancer accounts for 2% to 3% of systemic tumors. Among malignant tumors of the urinary system, its incidence is second only to bladder cancer, and it is increasing year by year. In recent years, targeted therapy and precision therapy have become standard treatments for kidney cancer.

Market Analysis and Insights: Global Renal Cell Cancer Treatment Market
The global Renal Cell Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Renal Cell Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Renal Cell Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Renal Cell Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Renal Cell Cancer Treatment market.

Global Renal Cell Cancer Treatment Scope and Market Size
Renal Cell Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Renal Cell Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibody
mTOR Inhibitors
Kinase Inhibitors
Other

Segment by Application
Hospital
Pharmacy
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Bristol-Myers Squibb
Roche
GSK
Novartis
Bayer
Merck & Co.
Exelixis
Takeda
Eisai
CTTQ
AVEO Oncology
Everest Pharm
Cipla
NATCO
Beacon Pharma
SAMARTH

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Cell Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibody
1.2.3 mTOR Inhibitors
1.2.4 Kinase Inhibitors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Renal Cell Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Renal Cell Cancer Treatment Market Perspective (2016-2027)
2.2 Renal Cell Cancer Treatment Growth Trends by Regions
2.2.1 Renal Cell Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Cell Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Renal Cell Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Renal Cell Cancer Treatment Industry Dynamic
2.3.1 Renal Cell Cancer Treatment Market Trends
2.3.2 Renal Cell Cancer Treatment Market Drivers
2.3.3 Renal Cell Cancer Treatment Market Challenges
2.3.4 Renal Cell Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Renal Cell Cancer Treatment Players by Revenue
3.1.1 Global Top Renal Cell Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Renal Cell Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Renal Cell Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Cell Cancer Treatment Revenue
3.4 Global Renal Cell Cancer Treatment Market Concentration Ratio
3.4.1 Global Renal Cell Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Cell Cancer Treatment Revenue in 2020
3.5 Renal Cell Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Renal Cell Cancer Treatment Product Solution and Service
3.7 Date of Enter into Renal Cell Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Renal Cell Cancer Treatment Breakdown Data by Type
4.1 Global Renal Cell Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Renal Cell Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Renal Cell Cancer Treatment Breakdown Data by Application
5.1 Global Renal Cell Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Renal Cell Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Renal Cell Cancer Treatment Market Size (2016-2027)
6.2 North America Renal Cell Cancer Treatment Market Size by Type
6.2.1 North America Renal Cell Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Renal Cell Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Renal Cell Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Renal Cell Cancer Treatment Market Size by Application
6.3.1 North America Renal Cell Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Renal Cell Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Renal Cell Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Renal Cell Cancer Treatment Market Size by Country
6.4.1 North America Renal Cell Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Renal Cell Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Renal Cell Cancer Treatment Market Size (2016-2027)
7.2 Europe Renal Cell Cancer Treatment Market Size by Type
7.2.1 Europe Renal Cell Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Renal Cell Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Renal Cell Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Renal Cell Cancer Treatment Market Size by Application
7.3.1 Europe Renal Cell Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Renal Cell Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Renal Cell Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Renal Cell Cancer Treatment Market Size by Country
7.4.1 Europe Renal Cell Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Renal Cell Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Renal Cell Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Renal Cell Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Renal Cell Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Cell Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Cell Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Cell Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Renal Cell Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Cell Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Cell Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Cell Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Renal Cell Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Cell Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Renal Cell Cancer Treatment Market Size (2016-2027)
9.2 Latin America Renal Cell Cancer Treatment Market Size by Type
9.2.1 Latin America Renal Cell Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Renal Cell Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Renal Cell Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Renal Cell Cancer Treatment Market Size by Application
9.3.1 Latin America Renal Cell Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Renal Cell Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Renal Cell Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Renal Cell Cancer Treatment Market Size by Country
9.4.1 Latin America Renal Cell Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Renal Cell Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Renal Cell Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Renal Cell Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Renal Cell Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Cell Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Cell Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Cell Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Renal Cell Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Cell Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Cell Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Cell Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Renal Cell Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Cell Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Renal Cell Cancer Treatment Introduction
11.1.4 Pfizer Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Renal Cell Cancer Treatment Introduction
11.2.4 Bristol-Myers Squibb Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Renal Cell Cancer Treatment Introduction
11.3.4 Roche Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.3.5 Roche Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Renal Cell Cancer Treatment Introduction
11.4.4 GSK Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.4.5 GSK Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Renal Cell Cancer Treatment Introduction
11.5.4 Novartis Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Renal Cell Cancer Treatment Introduction
11.6.4 Bayer Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.6.5 Bayer Recent Development
11.7 Merck & Co.
11.7.1 Merck & Co. Company Details
11.7.2 Merck & Co. Business Overview
11.7.3 Merck & Co. Renal Cell Cancer Treatment Introduction
11.7.4 Merck & Co. Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.7.5 Merck & Co. Recent Development
11.8 Exelixis
11.8.1 Exelixis Company Details
11.8.2 Exelixis Business Overview
11.8.3 Exelixis Renal Cell Cancer Treatment Introduction
11.8.4 Exelixis Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.8.5 Exelixis Recent Development
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Renal Cell Cancer Treatment Introduction
11.9.4 Takeda Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.9.5 Takeda Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Renal Cell Cancer Treatment Introduction
11.10.4 Eisai Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.10.5 Eisai Recent Development
11.11 CTTQ
11.11.1 CTTQ Company Details
11.11.2 CTTQ Business Overview
11.11.3 CTTQ Renal Cell Cancer Treatment Introduction
11.11.4 CTTQ Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.11.5 CTTQ Recent Development
11.12 AVEO Oncology
11.12.1 AVEO Oncology Company Details
11.12.2 AVEO Oncology Business Overview
11.12.3 AVEO Oncology Renal Cell Cancer Treatment Introduction
11.12.4 AVEO Oncology Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.12.5 AVEO Oncology Recent Development
11.13 Everest Pharm
11.13.1 Everest Pharm Company Details
11.13.2 Everest Pharm Business Overview
11.13.3 Everest Pharm Renal Cell Cancer Treatment Introduction
11.13.4 Everest Pharm Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.13.5 Everest Pharm Recent Development
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Renal Cell Cancer Treatment Introduction
11.14.4 Cipla Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.14.5 Cipla Recent Development
11.15 NATCO
11.15.1 NATCO Company Details
11.15.2 NATCO Business Overview
11.15.3 NATCO Renal Cell Cancer Treatment Introduction
11.15.4 NATCO Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.15.5 NATCO Recent Development
11.16 Beacon Pharma
11.16.1 Beacon Pharma Company Details
11.16.2 Beacon Pharma Business Overview
11.16.3 Beacon Pharma Renal Cell Cancer Treatment Introduction
11.16.4 Beacon Pharma Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.16.5 Beacon Pharma Recent Development
11.17 SAMARTH
11.17.1 SAMARTH Company Details
11.17.2 SAMARTH Business Overview
11.17.3 SAMARTH Renal Cell Cancer Treatment Introduction
11.17.4 SAMARTH Revenue in Renal Cell Cancer Treatment Business (2016-2021)
11.17.5 SAMARTH Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Renal Cell Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of mTOR Inhibitors
Table 4. Key Players of Kinase Inhibitors
Table 5. Key Players of Other
Table 6. Global Renal Cell Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Renal Cell Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Renal Cell Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Renal Cell Cancer Treatment Market Share by Regions (2016-2021)
Table 10. Global Renal Cell Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Renal Cell Cancer Treatment Market Share by Regions (2022-2027)
Table 12. Renal Cell Cancer Treatment Market Trends
Table 13. Renal Cell Cancer Treatment Market Drivers
Table 14. Renal Cell Cancer Treatment Market Challenges
Table 15. Renal Cell Cancer Treatment Market Restraints
Table 16. Global Renal Cell Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Renal Cell Cancer Treatment Market Share by Players (2016-2021)
Table 18. Global Top Renal Cell Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Cell Cancer Treatment as of 2020)
Table 19. Ranking of Global Top Renal Cell Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Renal Cell Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Renal Cell Cancer Treatment Product Solution and Service
Table 23. Date of Enter into Renal Cell Cancer Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Renal Cell Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Renal Cell Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Renal Cell Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Renal Cell Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Renal Cell Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Renal Cell Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Renal Cell Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Renal Cell Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Renal Cell Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Renal Cell Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Renal Cell Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Renal Cell Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Renal Cell Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Renal Cell Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Renal Cell Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Renal Cell Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Renal Cell Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Renal Cell Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Renal Cell Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Renal Cell Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Renal Cell Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Renal Cell Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Renal Cell Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Renal Cell Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Renal Cell Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Renal Cell Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Renal Cell Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Renal Cell Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Renal Cell Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Renal Cell Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Renal Cell Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Renal Cell Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Renal Cell Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Renal Cell Cancer Treatment Product
Table 66. Pfizer Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Renal Cell Cancer Treatment Product
Table 71. Bristol-Myers Squibb Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Renal Cell Cancer Treatment Product
Table 76. Roche Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. GSK Company Details
Table 79. GSK Business Overview
Table 80. GSK Renal Cell Cancer Treatment Product
Table 81. GSK Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 82. GSK Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis Renal Cell Cancer Treatment Product
Table 86. Novartis Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Renal Cell Cancer Treatment Product
Table 91. Bayer Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 92. Bayer Recent Development
Table 93. Merck & Co. Company Details
Table 94. Merck & Co. Business Overview
Table 95. Merck & Co. Renal Cell Cancer Treatment Product
Table 96. Merck & Co. Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 97. Merck & Co. Recent Development
Table 98. Exelixis Company Details
Table 99. Exelixis Business Overview
Table 100. Exelixis Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 101. Exelixis Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Renal Cell Cancer Treatment Product
Table 105. Takeda Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 106. Takeda Recent Development
Table 107. Eisai Company Details
Table 108. Eisai Business Overview
Table 109. Eisai Renal Cell Cancer Treatment Product
Table 110. Eisai Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 111. Eisai Recent Development
Table 112. CTTQ Company Details
Table 113. CTTQ Business Overview
Table 114. CTTQ Renal Cell Cancer Treatment Product
Table 115. CTTQ Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 116. CTTQ Recent Development
Table 117. AVEO Oncology Company Details
Table 118. AVEO Oncology Business Overview
Table 119. AVEO Oncology Renal Cell Cancer Treatment Product
Table 120. AVEO Oncology Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 121. AVEO Oncology Recent Development
Table 122. Everest Pharm Company Details
Table 123. Everest Pharm Business Overview
Table 124. Everest Pharm Renal Cell Cancer Treatment Product
Table 125. Everest Pharm Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 126. Everest Pharm Recent Development
Table 127. Cipla Company Details
Table 128. Cipla Business Overview
Table 129. Cipla Renal Cell Cancer Treatment Product
Table 130. Cipla Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 131. Cipla Recent Development
Table 132. NATCO Company Details
Table 133. NATCO Business Overview
Table 134. NATCO Renal Cell Cancer Treatment Product
Table 135. NATCO Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 136. NATCO Recent Development
Table 137. Beacon Pharma Company Details
Table 138. Beacon Pharma Business Overview
Table 139. Beacon Pharma Renal Cell Cancer Treatment Product
Table 140. Beacon Pharma Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 141. Beacon Pharma Recent Development
Table 142. SAMARTH Company Details
Table 143. SAMARTH Business Overview
Table 144. SAMARTH Renal Cell Cancer Treatment Product
Table 145. SAMARTH Revenue in Renal Cell Cancer Treatment Business (2016-2021) & (US$ Million)
Table 146. SAMARTH Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Cell Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibody Features
Figure 3. mTOR Inhibitors Features
Figure 4. Kinase Inhibitors Features
Figure 5. Other Features
Figure 6. Global Renal Cell Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Renal Cell Cancer Treatment Report Years Considered
Figure 11. Global Renal Cell Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Renal Cell Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Renal Cell Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Renal Cell Cancer Treatment Market Share by Regions (2022-2027)
Figure 15. Global Renal Cell Cancer Treatment Market Share by Players in 2020
Figure 16. Global Top Renal Cell Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Cell Cancer Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Renal Cell Cancer Treatment Revenue in 2020
Figure 18. Global Renal Cell Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Renal Cell Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Renal Cell Cancer Treatment Market Share by Type (2016-2027)
Figure 22. North America Renal Cell Cancer Treatment Market Share by Application (2016-2027)
Figure 23. North America Renal Cell Cancer Treatment Market Share by Country (2016-2027)
Figure 24. United States Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Renal Cell Cancer Treatment Market Share by Type (2016-2027)
Figure 28. Europe Renal Cell Cancer Treatment Market Share by Application (2016-2027)
Figure 29. Europe Renal Cell Cancer Treatment Market Share by Country (2016-2027)
Figure 30. Germany Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Renal Cell Cancer Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Renal Cell Cancer Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Renal Cell Cancer Treatment Market Share by Region (2016-2027)
Figure 40. China Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Renal Cell Cancer Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Renal Cell Cancer Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Renal Cell Cancer Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Renal Cell Cancer Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Renal Cell Cancer Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Renal Cell Cancer Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Renal Cell Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 65. Merck & Co. Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 66. Exelixis Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 67. Takeda Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 68. Eisai Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 69. CTTQ Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 70. AVEO Oncology Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 71. Everest Pharm Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 72. Cipla Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 73. NATCO Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 74. Beacon Pharma Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 75. SAMARTH Revenue Growth Rate in Renal Cell Cancer Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5819 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓癌＆腎細胞癌（RCC）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アフィニトール（エベロリムス）、アバスチン（ベバシズマブ）、カボメティ（カボザンチニブ）、インリタ（アキシチニブ）、ネク...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の末期腎疾患治療市場規模・現状・予測（2021年-2027年）

Global End Stage Renal Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4184 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、末期腎疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（移植、透析）、用途別市場規模（公立病院、私立病院）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous B-Cell Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4075 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、皮膚B細胞リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体療法、その他）、用途別市場規模（病院、診療所、外来外科センター、その他）、主要地域別市場規...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界の精巣がん治療市場規模・現状・予測（2021年-2027年）

Global Testicular Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4948 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、精巣がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、経口剤）、用途別市場規模（病院薬局、小売薬局、専門がんクリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年）

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3894 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B細胞非ホジキンリンパ腫（NHL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米...

世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年） Kidney cancer/ renal cell carcinoma (RCC) is among ten most commonly observed cancer these days. It is sixth common cancer observed in men and it is the tenth most common cause of cancer for women. Market Analysis and Insights: Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market The glo…
世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…
世界の末期腎疾患治療市場規模・現状・予測（2021年-2027年） Any condition that causes reduced kidney function leads to chronic kidney disease (CKD), which may develop over a period and lead to end stage renal disease (ESRD), where kidney can no longer function on their own. It is also termed as kidney or renal failure. Factors contributing to the formation o…
世界の腎臓癌治療市場規模・現状・予測（2021年-2027年） Kidney cancer -- also called renal cancer -- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma…
世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…